Nanotechnology Now

• About Us
  
  • Advertising
  • Our Mission
  • Our Team
  • Comments
  • Friends
  • Contact
• Nanotechnology
• News
  
  • Current News
  • Press Releases
  • Submit Press
  • Press kit
  • Interviews
• Columns
• Products
  
  • Our Products
  • Books
  • Featured Books
• Directories
  
  • Companies/Academic
  • Events
  • Glossary
  • Best Of
• Career Center
• Nano-Social Network
• Nano Consulting
• My Account

Home > News > Biocon and Abraxis announce approval of Abraxane in India

November 29th, 2007

Biocon and Abraxis announce approval of Abraxane in India

Abstract:
Biocon and Abraxis BioScience, an integrated global biopharmaceutical company, have announced the approval by the country's Drug Controller General to market Abraxane for injectable suspension (paclitaxel protein-bound particles) in India for the treatment of breast cancer. Commercial introduction of Abraxane in the Indian market is expected in 2008, following the completion of the appropriate importation certifications. "The approval of Abraxane in India is an important step in providing access to the NAB (nanoparticle albumin bound) technology globally," said Patrick Soon-Shiong, Managing Director, Chairman and Chief Executive Officer of Abraxis. "In partnership with Biocon, we are excited to offer physicians in India this important advance in the treatment of breast cancer."

Source:
expresspharmaonline.com

Bookmark:

Related News Press

Govt.-Legislation/Regulation/Funding/Policy

Sound waves precisely position nanowires June 19th, 2013

3-D printing could lead to tiny medical implants, electronics, robots, more June 18th, 2013

Working backward: Computer-aided design of zeolite templates: Rice scientists apply drug-design lessons to production of industrial minerals June 17th, 2013

An Innovative material for the Green Earth: Simple and inexpensive process to make a material for CO2 adsorption June 17th, 2013

Nanomedicine

Production of Bioactive Material for Quick Treatment of Bone Damages June 19th, 2013

3-D printing could lead to tiny medical implants, electronics, robots, more June 18th, 2013

Pioneering breakthrough of chemical nanoengineering to design drugs controlled by light June 18th, 2013

Study Shows How the Nanog Protein Promotes Growth of Head and Neck Cancer June 18th, 2013

Announcements

Sound waves precisely position nanowires June 19th, 2013

Scientists Use Nanotechnology to Increase Thermal Stability of Essential Oils June 19th, 2013

Production of Bioactive Material for Quick Treatment of Bone Damages June 19th, 2013

Nanometrics Announces Participation in 5th Annual CEO Investor Summit: Accredited Investor and Publishing Research Analyst Event to be Held Concurrently With SEMICON West and Intersolar 2013 in San Francisco June 19th, 2013